Member-only story
Artificial Intelligence Darling Palantir Has New Deal With Leading Clinical Research Organization
An emerging leader in AI continues to build strong business partnerships
Surging artificial intelligence systems builder Palantir (PLTR) has been steadily stockpiling investor support through strong proof of concept, financials and company growth. Primarily known for its work with the U.S. military, the company actually has a varied client list, which is only expanding. They just announced their newest partnership, a multi-year deal with Parexel, a clinical research organization that offers clinical development services from Phase I to IV, and is considered among the global leaders in their industry.
Parexel described themselves and what their new collaboration will look like in the official announcement:
“Parexel is a leader in the CRO industry in enhancing and accelerating the clinical trial lifecycle utilizing its Parexel Precision Pathway, an end-to-end operational approach that prioritizes the timely delivery of clean data while driving efficiency, quality and predictability. Supported by Palantir’s industry-leading software, Parexel’s clinical data platform provides an integrated digital environment to hyper-automate manual processes, safely promote data discoverability…
